| The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease D Pastori, L Polimeni, F Baratta, A Pani, M Del Ben, F Angelico Digestive and Liver Disease 47 (1), 4-11, 2015 | 225 | 2015 |
| Macrolides and viral infections: focus on azithromycin in COVID-19 pathology A Pani, M Lauriola, A Romandini, F Scaglione International journal of antimicrobial agents 56 (2), 106053, 2020 | 147 | 2020 |
| Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management P Pignatelli, E Ettorre, D Menichelli, A Pani, F Violi, D Pastori Haematologica 105 (3), 562, 2020 | 118 | 2020 |
| Antibiotic resistance in pediatric infections: global emerging threats, predicting the near future A Romandini, A Pani, PA Schenardi, GAC Pattarino, C De Giacomo, ... Antibiotics 10 (4), 393, 2021 | 98 | 2021 |
| Differences in PARP inhibitors for the treatment of ovarian cancer: mechanisms of action, pharmacology, safety, and efficacy G Valabrega, G Scotto, V Tuninetti, A Pani, F Scaglione International journal of molecular sciences 22 (8), 4203, 2021 | 71 | 2021 |
| Neuroimaging in vascular cognitive impairment and dementia: a systematic review V Frantellizzi, A Pani, M Ricci, N Locuratolo, F Fattapposta, ... Journal of Alzheimer's Disease 73 (4), 1279-1294, 2020 | 60 | 2020 |
| New frontiers in molecular imaging with superparamagnetic iron oxide nanoparticles (SPIONs): efficacy, toxicity, and future applications V Frantellizzi, M Conte, M Pontico, A Pani, R Pani, G De Vincentis Nuclear medicine and molecular imaging 54, 65-80, 2020 | 59 | 2020 |
| Targeted alpha therapy with thorium-227 V Frantellizzi, L Cosma, G Brunotti, A Pani, A Spanu, S Nuvoli, ... Cancer biotherapy & radiopharmaceuticals 35 (6), 437-445, 2020 | 56 | 2020 |
| Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis D Pastori, A Pani, A Di Rocco, D Menichelli, G Gazzaniga, A Farcomeni, ... British Journal of Clinical Pharmacology 88 (2), 441-451, 2022 | 55 | 2022 |
| Effect of combination therapy of hydroxychloroquine and azithromycin on mortality in patients with COVID‐19 M Lauriola, A Pani, G Ippoliti, A Mortara, S Milighetti, M Mazen, ... Clinical and translational science 13 (6), 1071-1076, 2020 | 55 | 2020 |
| CDK4/6 inhibitors in breast cancer treatment: potential interactions with drug, gene, and pathophysiological conditions R Roncato, J Angelini, A Pani, E Cecchin, A Sartore-Bianchi, S Siena, ... International journal of molecular sciences 21 (17), 6350, 2020 | 50 | 2020 |
| Strategies to tackle RAS-mutated metastatic colorectal cancer G Patelli, F Tosi, A Amatu, G Mauri, A Curaba, DA Patane, A Pani, ... ESMO open 6 (3), 100156, 2021 | 47 | 2021 |
| Off-label use of ceftaroline fosamil: a systematic review A Pani, F Colombo, F Agnelli, V Frantellizzi, F Baratta, D Pastori, ... International journal of antimicrobial agents 54 (5), 562-571, 2019 | 44 | 2019 |
| From prediabetes to type 2 diabetes mellitus in women with polycystic ovary syndrome: lifestyle and pharmacological management A Pani, I Gironi, G Di Vieste, E Mion, F Bertuzzi, B Pintaudi International Journal of Endocrinology 2020 (1), 6276187, 2020 | 39 | 2020 |
| Inositol and non-alcoholic fatty liver disease: a systematic review on deficiencies and supplementation A Pani, R Giossi, D Menichelli, VA Fittipaldo, F Agnelli, E Inglese, ... Nutrients 12 (11), 3379, 2020 | 36 | 2020 |
| Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors D Pastori, L Loffredo, L Perri, F Baratta, L Scardella, L Polimeni, A Pani, ... The American Journal of Cardiology 115 (10), 1402-1406, 2015 | 36 | 2015 |
| Similar reduction of cholesterol-adjusted vitamin E serum levels in simple steatosis and non-alcoholic steatohepatitis D Pastori, F Baratta, R Carnevale, R Cangemi, M Del Ben, T Bucci, ... Clinical and translational gastroenterology 6 (10), e113, 2015 | 30 | 2015 |
| A systematic review and a meta-analysis comparing prophylactic and therapeutic low molecular weight heparins for mortality reduction in 32,688 COVID-19 patients R Giossi, D Menichelli, A Pani, E Tratta, A Romandini, R Roncato, A Nani, ... Frontiers in pharmacology 12, 698008, 2021 | 25 | 2021 |
| Pneumatosis intestinalis induced by anticancer treatment: a systematic review G Gazzaniga, F Villa, F Tosi, EG Pizzutilo, S Colla, S D’Onghia, ... Cancers 14 (7), 1666, 2022 | 23 | 2022 |
| Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine R Crocchiolo, AM Gallina, A Pani, D Campisi, V Cento, N Sacchi, V Miotti, ... Hla 99 (3), 183-191, 2022 | 21 | 2022 |
